$CME

DUFFY TERRENCE A sold $4.1M of CME

DUFFY TERRENCE A (Chairman and CEO) sold 15,000 shares of CME GROUP INC. (CME) at an average of $274.44 ($274.41–$275.03, $4.12M total) across 2 trades on 2026-09-10.

Original reporting
SEC EDGAR · DUFFY TERRENCE A
Published Sep 11, 2026, 9:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 11:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CME
Bearish
medium confidence
Mentioned
$CME
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CMEBearishLow
01

Why it matters

The CEO's sale reduces his ownership, which may be interpreted by the market as a lack of confidence.

02

Market read

Insider sales are closely watched; this filing provides fresh data for traders.

03

What to watch

Potential upcoming corporate actions or compensation plans not disclosed.

Relevance 6/10Novelty 7/10Timing: post‑market 2026‑09‑10

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$CMEBearishMedium confidence
Context

CEO Terrence Duffy sold 15,000 shares for $4.1M, reducing his stake to 40,630 shares.

Expected impact

Possible short‑term dip or increased volatility.

Evidence & confidence

Sale size is material for a large‑cap, but no other catalyst is present.

Market effects

Minimal impact on financial services sector; may prompt scrutiny of other insider activity.

Negligible effect on broader U.S. market.

Limited to investors tracking CME Group.

Counterpoint

The sale could be routine portfolio rebalancing, not a bearish signal.

Key entities

  • CME Group Inc.

    Operator of global derivatives exchanges.

  • Terrence Duffy

    Chairman and CEO of CME Group.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CMEMed

CME to launch Bitcoin Cash and Uniswap futures, expand altcoin lineup

CME Group plans to launch Bitcoin Cash (BCH) and Uniswap (UNI) futures on Oct. 19, pending regulatory approval. The products will include standard and micro contracts. CME aims to meet demand from institutions and traders seeking regulated altcoin exposure. The exchange has seen strong trading performance in crypto futures, with average daily volume of 279,800 contracts in the first half of 2026.

$MAHighAI 9/10

BVNK adds Stellar rail after Mastercard closes $1.8B deal

BVNK launched Stellar integration for enterprise customers globally following Mastercard's $1.8B acquisition. Binance withdrawals averaged 90,000 monthly, with ETH above $2,700. Kalshi filed for SEC and CFTC approval to list perpetual security futures. CME will add Bitcoin Cash and Uniswap futures on October 19.

$CMELow

FutureSports to create world's first broad-based indexes on MLB team performance

FutureSports and MLB agreed to create indexes on team performance, enabling CME Group to list futures contracts. The indexes, called CME FSPI, will be based on official league data and aim to provide hedging and investment opportunities. FutureSports and CME Group will maintain transparency and integrity, with MLB having no role in index determination. Similar indexes for NHL teams are planned to launch soon.

$CMELow

How New Loan Futures At CME Group (CME) Has Changed Its Investment Story

CME Group launched new S&P UBS USD Liquid Leveraged Loan Index futures on September 14, alongside strong activity in 24/7 gold and silver contracts. The company aims to widen hedging tools and attract more users. CME Group's revenue is projected to reach US$8.0b by 2029, with a 5.6% yearly growth rate. The launch of CME Securities Clearing in U.S. Treasuries is another key development.